Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.74
-0.19 (-2.40%)
At close: Nov 20, 2026, 4:00 PM EST
8.16
+0.42 (5.43%)
After-hours: Nov 20, 2026, 7:56 PM EST
Moleculin Biotech Stock Forecast
MBRX's stock price has decreased by -96.47% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Moleculin Biotech stock has a consensus rating of "Strong Buy" and an average price target of $240. The average 1-year stock price forecast is 3,000.78% higher than the current stock price, while the lowest is $40 (+416.80%) and the highest is $620 (+7,910.34%).
Price Target: $240 (+3,000.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Moleculin Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $40 | Buy | Maintains | $40 | +416.80% | Nov 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $60 | Buy | Maintains | $60 | +675.19% | Sep 29, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $620 | Buy | Maintains | $620 | +7,910.34% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.43K
from -955.52
EPS Next Year
-2.21K
from -2.43K
EPS and Forward PE are based on non-GAAP adjusted numbers.